Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Amortization of Goodwill (2023 - 2024)

Lexaria Bioscience's Amortization of Goodwill history spans 2 years, with the latest figure at $34329.0 for Q2 2024.

  • For Q2 2024, Amortization of Goodwill changed N/A year-over-year to $34329.0; the TTM value through Aug 2024 reached $141090.0, changed N/A, while the annual FY2024 figure was $57836.0, 45.83% down from the prior year.
  • Amortization of Goodwill for Q2 2024 was $34329.0 at Lexaria Bioscience, down from $106761.0 in the prior quarter.
  • Across five years, Amortization of Goodwill topped out at $106761.0 in Q3 2023 and bottomed at $34329.0 in Q2 2024.